Dr. Lodge is the Chief Science and Innovation Officer at Cellero. She has a strong background in cell-based therapeutics and immunology, including a Ph.D. in Cell and Molecular Biology from the University of Vermont and a postdoctoral fellowship with the Multiple Sclerosis Society studying the role of T cells in the disease process. Learn more about Dr. Lodge.

The Rise of Specialty Drugs and the Impact on Market Growth

Specialty drugs — often described as “prescription drugs that are difficult to manufacture and require special handling or administration, have limited distribution, target a narrow group of chronic diseases, are costly, and require ongoing clinical support — will drive nearly all of the pharmaceutical industry’s market growth from 2015–2020. Drug Channels projects the total pharmaceutical…

Cells in Motion: Immune and Cancer Cells

At the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, researchers from Biodesix presented a poster featuring our cells. The poster, “Development of ddPCR blood-based diagnostic tests that simultaneously measure mRNA expression from immune and cancer cells,” demonstrates how Biodesix developed sensitive and specific methods that can be applied in gene expression studies in blood. These…